Company intelligence / Profile preview

Orap

Bridgewater, New Jersey, United States

Ownership: Private
Employees: ~250
Development stage: Other

Overview

OraPharma is a specialty pharmaceutical company focused on developing and commercializing products for the dental and oral healthcare market. The company is best known for Arestin (minocycline hydrochloride), a locally administered antibiotic used as an adjunct to scaling and root planing procedures for the treatment of periodontitis. OraPharma also provides a range of other dental solutions, including bone grafting materials and diagnostic tools. Currently operating as a subsidiary of Bausch Health, the company maintains a dedicated sales force targeting dental professionals across the United States.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeDeviceBiologic
Industry: Biotech

Beyond the preview

Go deeper on Orap.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orap.

Explore the full profile